Monitoring of Suspected Adverse Drug Reactions in Oncology Unit of an Urban Multispeciality Teaching Hospital

Amartya De

2010 · 11 citations · 10 references

Concepts

Abstract

Adverse drug reactions (ADRs) are a global problem and substantially add to the cost of healthcare. They are likely to be encountered more frequently in hospital in-patient settings where patients receive multiple drugs. Anticancer drugs are prone to cause ADRs and there is dearth of pharmacovigilance data on such drugs in the Indian context. Therefore the present study was planned to monitor suspected ADRs in the oncology unit of a tertiary care teaching hospital, in a focused manner, and to understand the strengths and limitations of cross-sectional observational pharmacovigilance activity for anticancer drugs. A total of 509 drugs were incriminated, with 507 being administered by intravenous route. The most frequently incriminated drugs (those accounting for more than 5% of the total count of 509) were cisplatin, 5-fluorouracil, cyclophosphamide, paclitaxel, carboplatin and doxorubicin, in that order. Of the 296 events, 9.83% were severe and 5.76% were serious. However, there were no fatal or life-threatening events. Causality assessment showed a certain association for 1.84% of the events, probable or likely association for 85.28% and possible association for 12.88%. There was no event less convincing than possible. The frequency of ADRs, easy identification of acute treatment-emergent events and the cooperation offered by patients in the clinical surroundings were the strengths of this method of monitoring for suspected ADRs. On the other hand, the limitations were the inability to identify ADRs that require serial clinical or laboratory monitoring and the lack of scope for picking up chronic or delayed ADRs.

References

10